Genome-scale analysis of anti-metabolite directed strain engineering.

Classic strain engineering methods have previously been limited by the low-throughput of conventional sequencing technology. Here, we applied a new genomics technology, scalar analysis of library enrichments (SCALEs), to measure >3 million Escherichia coli genomic library clone enrichment patterns resulting from growth selections employing three aspartic-acid anti-metabolites. Our objective was to assess the extent to which access to genome-scale enrichment patterns would provide strain-engineering insights not reasonably accessible through the use of conventional sequencing. We determined that the SCALEs method identified a surprisingly large range of anti-metabolite tolerance regions (423, 865, or 909 regions for each of the three anti-metabolites) when compared to the number of regions (1-3 regions) indicated by conventional sequencing. Genome-scale methods uniquely enable the calculation of clone fitness values by providing concentration data for all clones within a genomic library before and after a period of selection. We observed that clone fitness values differ substantially from clone concentration values and that this is due to differences in overall clone fitness distributions for each selection. Finally, we show that many of the clones of highest fitness overlapped across all selections, suggesting that inhibition of aspartate metabolism, as opposed to specific inhibited enzymes, dominated each selection. Our follow up studies confirmed our observed growth phenotypes and showed that intracellular amino-acid levels were also altered in several of the identified clones. These results demonstrate that genome-scale methods, such as SCALEs, can be used to dramatically improve understanding of classic strain engineering approaches.

[1]  K. Lewis,et al.  An E. coli gene emrD is involved in adaptation to low energy shock. , 1993, Biochemical and biophysical research communications.

[2]  R. Gill,et al.  Reverse Engineering Antibiotic Sensitivity in a Multidrug-Resistant Pseudomonas aeruginosa Isolate , 2006, Antimicrobial Agents and Chemotherapy.

[3]  Ronald W. Davis,et al.  Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.

[4]  G. Stephanopoulos,et al.  Genome-wide screening for trait conferring genes using DNA microarrays , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Yamaguchi,et al.  Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli , 2001, Journal of bacteriology.

[6]  A. Demain Overproduction of microbial metabolites and enzymes due to alteration of regulation , 1971 .

[7]  G. Stephanopoulos,et al.  Exploiting biological complexity for strain improvement through systems biology , 2004, Nature Biotechnology.

[8]  J. Preston,et al.  The pgaABCD Locus of Escherichia coli Promotes the Synthesis of a Polysaccharide Adhesin Required for Biofilm Formation , 2004, Journal of bacteriology.

[9]  M. Valvano,et al.  Genetic analysis of the O-specific lipopolysaccharide biosynthesis region (rfb) of Escherichia coli K-12 W3110: identification of genes that confer group 6 specificity to Shigella flexneri serotypes Y and 4a , 1994, Journal of Bacteriology.

[10]  L Wodicka,et al.  Parallel analysis of genetic selections using whole genome oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Villafranca,et al.  Interaction of aspartate and aspartate-derived antimetabolites with the enzymes of the threonine biosynthetic pathway of Escherichia coli. , 1984, The Journal of biological chemistry.

[12]  F. Neidhardt,et al.  Escherichia Coli and Salmonella: Typhimurium Cellular and Molecular Biology , 1987 .

[13]  Ryan T Gill,et al.  SCALEs: multiscale analysis of library enrichment , 2007, Nature Methods.

[14]  R. Lenski,et al.  Parallel changes in gene expression after 20,000 generations of evolution in Escherichia coli , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ronald W. Davis,et al.  Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.

[16]  S. Wong,et al.  Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa , 1984, Antimicrobial Agents and Chemotherapy.

[17]  Ronald W. Davis,et al.  Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar–coding strategy , 1996, Nature Genetics.

[18]  S. P. Fodor,et al.  Multiplexed biochemical assays with biological chips , 1993, Nature.

[19]  Ryan T Gill,et al.  A comparative study of metabolic engineering anti-metabolite tolerance in Escherichia coli. , 2006, Metabolic engineering.

[20]  G. Stephanopoulos,et al.  Engineering Yeast Transcription Machinery for Improved Ethanol Tolerance and Production , 2006, Science.

[21]  Vassily Hatzimanikatis,et al.  Inverse metabolic engineering: a strategy for directed genetic engineering of useful phenotypes. , 2002, Biotechnology and bioengineering.

[22]  C. Drainas,et al.  Aspartic Hydroxamate Resistance and Asparaginase Regulation in the Fungus Aspergillus nidulans , 1977 .

[23]  F. Neidhardt,et al.  Culture Medium for Enterobacteria , 1974, Journal of bacteriology.

[24]  J. Shendure,et al.  Selection analyses of insertional mutants using subgenic-resolution arrays , 2001, Nature Biotechnology.

[25]  Ryan T Gill,et al.  Amino acid content of recombinant proteins influences the metabolic burden response. , 2005, Biotechnology and bioengineering.

[26]  D. Oxender,et al.  Transport Systems for Alanine, Serine, and Glycine in Escherichia coli K-12 , 1973, Journal of bacteriology.

[27]  M. Saier,et al.  The β‐barrel finder (BBF) program, allowing identification of outer membrane β‐barrel proteins encoded within prokaryotic genomes , 2002 .

[28]  J. Keasling,et al.  Guanosine pentaphosphate phosphohydrolase of Escherichia coli is a long-chain exopolyphosphatase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Gill,et al.  Broad host range vectors for stable genomic library construction , 2006, Biotechnology and bioengineering.

[30]  M. Kates,et al.  Metabolic inhibitors : a comprehensive treatise , 1963 .

[31]  P. Tauc,et al.  L-alanosine: a noncooperative substrate for Escherichia coli aspartate transcarbamylase. , 1985, Biochemistry.

[32]  Peter D. Karp,et al.  EcoCyc: a comprehensive database resource for Escherichia coli , 2004, Nucleic Acids Res..

[33]  Manor Askenazi,et al.  Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains , 2003, Nature Biotechnology.

[34]  Richard E. Lenski,et al.  Rapid evolution in response to high-temperature selection , 1990, Nature.

[35]  R. Lenski,et al.  Microbial genetics: Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation , 2003, Nature Reviews Genetics.